|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0028351,
umls-concept:C0030685,
umls-concept:C0035096,
umls-concept:C0042380,
umls-concept:C0103306,
umls-concept:C0391871,
umls-concept:C0449432,
umls-concept:C0680255,
umls-concept:C1179435,
umls-concept:C1280500,
umls-concept:C1283071,
umls-concept:C1524073,
umls-concept:C1548799,
umls-concept:C1705248,
umls-concept:C1882714,
umls-concept:C1963578
|
|
pubmed:issue |
7
|
|
pubmed:dateCreated |
2003-6-20
|
|
pubmed:abstractText |
Angiotensin (Ang) is broken down enzymatically to several different metabolites which, in addition to Ang II, may have important biological effects in the kidney. This study investigates the role of Ang metabolites on vascular resistance and noradrenaline release in the rat kidney.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Aminopeptidases,
http://linkedlifedata.com/resource/pubmed/chemical/Angiotensin I,
http://linkedlifedata.com/resource/pubmed/chemical/Angiotensin II,
http://linkedlifedata.com/resource/pubmed/chemical/Angiotensin II Type 1 Receptor...,
http://linkedlifedata.com/resource/pubmed/chemical/Angiotensin II Type 2 Receptor...,
http://linkedlifedata.com/resource/pubmed/chemical/Angiotensin III,
http://linkedlifedata.com/resource/pubmed/chemical/Angiotensin-Converting Enzyme...,
http://linkedlifedata.com/resource/pubmed/chemical/Antihypertensive Agents,
http://linkedlifedata.com/resource/pubmed/chemical/Norepinephrine,
http://linkedlifedata.com/resource/pubmed/chemical/Peptide Fragments,
http://linkedlifedata.com/resource/pubmed/chemical/Vasoconstrictor Agents,
http://linkedlifedata.com/resource/pubmed/chemical/angiotensin I (1-7),
http://linkedlifedata.com/resource/pubmed/chemical/angiotensin II...
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jul
|
|
pubmed:issn |
0263-6352
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
21
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1391-9
|
|
pubmed:dateRevised |
2010-11-18
|
|
pubmed:meshHeading |
pubmed-meshheading:12817189-Aminopeptidases,
pubmed-meshheading:12817189-Angiotensin I,
pubmed-meshheading:12817189-Angiotensin II,
pubmed-meshheading:12817189-Angiotensin II Type 1 Receptor Blockers,
pubmed-meshheading:12817189-Angiotensin II Type 2 Receptor Blockers,
pubmed-meshheading:12817189-Angiotensin III,
pubmed-meshheading:12817189-Angiotensin-Converting Enzyme Inhibitors,
pubmed-meshheading:12817189-Animals,
pubmed-meshheading:12817189-Antihypertensive Agents,
pubmed-meshheading:12817189-Kidney,
pubmed-meshheading:12817189-Male,
pubmed-meshheading:12817189-Norepinephrine,
pubmed-meshheading:12817189-Peptide Fragments,
pubmed-meshheading:12817189-Rats,
pubmed-meshheading:12817189-Rats, Inbred WKY,
pubmed-meshheading:12817189-Renin-Angiotensin System,
pubmed-meshheading:12817189-Synaptic Transmission,
pubmed-meshheading:12817189-Vascular Resistance,
pubmed-meshheading:12817189-Vasoconstrictor Agents
|
|
pubmed:year |
2003
|
|
pubmed:articleTitle |
Effects of angiotensin-(1-7) and other bioactive components of the renin-angiotensin system on vascular resistance and noradrenaline release in rat kidney.
|
|
pubmed:affiliation |
Department of Internal Medicine I, Marienhospital Herne, Ruhr-University Bochum, Herne, Germany.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
